Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
about
Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled studyNewcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell deathMolecular targets of TRAIL-sensitizing agents in colorectal cancerSerial low doses of sorafenib enhance therapeutic efficacy of adoptive T cell therapy in a murine model by improving tumor microenvironmentTranscriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancerSynergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts.TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracilSnake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expressionRole of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.Synergistic Effect of Subtoxic-dose Cisplatin and TRAIL to Mediate Apoptosis by Down-regulating Decoy Receptor 2 and Up-regulating Caspase-8, Caspase-9 and Bax Expression on NCI-H460 and A549 Cells.Cellular FLICE-inhibitory protein: an attractive therapeutic target?Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest.Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.To kill a tumor cell: the potential of proapoptotic receptor agonistsHelicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIPA mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy.Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cellsEffect of TRAIL in combination with DDP on the expression of MDR1 gene in gastric cancer cells.Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL.Targeting death receptors: is this trail still hot?Phellinus linteus sensitises apoptosis induced by doxorubicin in prostate cancer.Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis.The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer.Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.Dual role of immunomodulation by anticancer chemotherapy.Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
P2860
Q24337211-25884D1F-0CB2-4AD6-A0DD-2FBACEDEFCDEQ24645666-8E7CEC7A-D9AA-4C9A-8729-885DC8B7B530Q24674186-C7F0899F-2BC2-434F-A0AA-A5A80CE48007Q26822382-B7BA297F-529B-4D24-9F9F-192E2E0C2BF5Q27335748-08893470-1F1D-420D-BD3D-2BF102F8728FQ28488566-617C4349-C00A-4B06-ABD4-10C6E2D7CC38Q33680928-3202C544-6A27-4AB9-B944-9DDA97C550BBQ33802588-006E4F85-B7AB-46B6-9BBA-32FB42386EDBQ33990012-21255509-C5EC-46CF-B1A8-8EC83BCBBFFCQ34297762-DF463A51-EA41-4569-A6B7-BABA90249A48Q34333852-A823DA7D-7D86-4D86-8667-5C06F7A8C29EQ34798109-88E56500-397A-4CE7-8239-3D7B06380686Q35186676-BA04BCEA-8631-470E-A13A-37DB591A4816Q35665706-EDAFFDD6-BA87-421F-BB4B-0700B7C5839EQ36309098-7510F652-175F-49F7-A865-C1FD912AAB72Q36338510-C9B6567A-19EF-4C0A-88BE-17898FC39EBCQ37139330-27B356AA-7D46-41BA-9DCD-2EB8EA68D627Q37178718-613826B4-2374-46AE-9CC6-4A0845F91767Q37181734-BFBB120C-8C39-4C23-A42D-1A8F8111E5C7Q37680159-8F09820C-E86A-4FC1-9B15-941486920DBDQ38307538-A882A135-079B-4B1F-812F-C7331C78902BQ38601593-1E887589-0A24-4AA9-98C3-DB6DE4E3115EQ38601765-EF044891-A289-404E-8792-F79959BAD6AFQ38798516-10CC75AF-B868-476E-9E4B-38DB050720A8Q38951203-228D79AF-058F-4EF2-92B7-FE0FBAAB1702Q39711397-CC9015E0-A2BC-4B51-9585-281BA7430F6AQ40033141-0A396D74-105F-403A-A96D-62DDA8BD2741Q40251505-86A32549-568A-494B-813F-8F6952FF84E2Q40463099-00077C71-06D4-42C5-8897-9A094CE9E274Q41978994-041E6C47-323E-43C9-B08B-447C9BFEFC45Q42124995-AA5CABD9-1FAE-495A-8287-01C705A7302AQ42631276-2F8C311A-D6B4-437E-BAB3-11131C59D5B7Q55362655-8D76795F-D1C0-4118-AB12-E94FFD5F3700
P2860
Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@en
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@nl
type
label
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@en
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@nl
prefLabel
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@en
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@nl
P2093
P1433
P1476
Anticancer agents sensitize tu ...... se-8 activation and apoptosis.
@en
P2093
Dimanche-Boitrel MT
P304
P407
P577
2001-02-01T00:00:00Z